A5063862796- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Structural Anomalies and Repair
- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Peripheral Artery Disease Management
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Vascular Procedures and Complications
- Cardiac pacing and defibrillation studies
- Mechanical Circulatory Support Devices
- Cardiac and Coronary Surgery Techniques
- Emergency and Acute Care Studies
- Aortic Disease and Treatment Approaches
- Cardiac Arrest and Resuscitation
- Trigeminal Neuralgia and Treatments
- Cancer Treatment and Pharmacology
- Chemotherapy-induced cardiotoxicity and mitigation
- Neurosurgical Procedures and Complications
- Occupational Health and Performance
- CNS Lymphoma Diagnosis and Treatment
- Lymphadenopathy Diagnosis and Analysis
- Mast cells and histamine
University of Colorado Health
2018-2023
Banner - University Medical Center Phoenix
2014-2019
Banner - University Medical Center Tucson
2017-2018
University of Arizona
2018
University of Washington
2017
Banner Health
2015-2016
Good Samaritan Medical Center
2014-2015
Mayo Clinic in Arizona
2014
Postinfarct VSD (PIVSD) carries a grim prognosis. The mainstay of management has been surgical repair. advent septal occluder devices offered an attractive alternative to Most PIVSD have serpiginous tracts with necrotic tissue, which makes assessing the defect challenging. 3D computer printing become useful in preprocedure planning complex procedures multiple subspecialties.
Abstract Introduction Patients with coronary chronic total occlusions (CTO) often have concurrent higher‐risk anatomy and physiology (significant calcium, left ventricular dysfunction, multivessel disease) that increase their procedural risk. We present a retrospective multicenter case series describing use of the Impella percutaneous assist device (p‐VAD) during CTO PCI. Methods performed analysis self‐reported data from five large referral centers 2013 to 2017 identified patients underwent...
There are non-randomized data about the benefits of Impella use in setting cardiogenic shock. However, limited exist to help guide clinicians whether context intervention device should be implanted early or late; how long stay in; and mode explant be.This is a retrospective, single center registry over 5 years comparing in-hospital outcomes 1-year mortality all-comers who had placed versus those late as bailout. The primary endpoint was composite all-cause mortality, major vascular, bleeding...
Patients who undergo trans-catheter aortic valve replacement (TAVR) may have concomitant aneurysms. We sought to clarify the incidence of aneurysms and its impact on clinical outcomes among patients undergoing TAVR.We performed a retrospective analysis with severe symptomatic stenosis underwent TAVR from January 2012 June 2016. Multi-detector computer tomography (MDCT) was all images were reviewed identify thoracic abdominal (TAA AAA). The vascular complications (VARC-2 definition),...
This study sought to identify patient and left atrial morphology specific factors associated with early complications for appendage occlusion the Watchman™ (Boston Scientific, Natick, MA) device.Oral anticoagulation (OAC) is recommended patients fibrillation, however, long-term OAC compliance poor. In randomized control trials, device has demonstrated superiority over warfarin all cause cardiovascular mortality hemorrhagic stroke. However, predictors of procedural have not yet been well...
Increased afterload and reduced left ventricular (LV) performance are sequela of mitral valve repair. However, hemodynamic atrial parameters that can predict outcome following repair remain elusive.One hundred two consecutive patients undergoing MitraClip procedure from 2014 to 2017 at Banner University Medical Center were enrolled in this study. All underwent pre-procedure echocardiograms intra-procedure invasive (LA) pressure monitoring. Clinical, laboratory, procedural collected. The...
This purpose of the study was to evaluate TAVR outcomes at low, intermediate and high volume institutions.For care complex patients, volume-outcome effect is well described. The initial US experience limited a few centers excellence. impact institutional on after has not been systematically studied.Within Banner Health system, performed 3 institutions-a low volume, an institution. 181 consecutive patients undergoing within these institutions were cohort. To adjust for bias confounders...
Objectives We report the 30-day outcomes from roll-in cohort of CLASP IID trial, representing first procedures performed by each site. Background The currently enrolling IID/IIF pivotal trial is a multicenter, prospective, randomized assessing safety and effectiveness PASCAL transcatheter valve repair system in patients with clinically significant MR. allows for up to three per Methods Eligibility criteria were: DMR ≥3+, prohibitive surgical risk, deemed suitable local heart team. Trial...
When performing a valve-in-valve transcatheter aortic valve replacement (TAVR) procedure, caution with respect to the risk of coronary occlusion is necessary. In addition, safety implanting percutaneous left ventricular-assist device through freshly implanted heart should be reinforced.